JP2016519767A5 - - Google Patents

Download PDF

Info

Publication number
JP2016519767A5
JP2016519767A5 JP2016505813A JP2016505813A JP2016519767A5 JP 2016519767 A5 JP2016519767 A5 JP 2016519767A5 JP 2016505813 A JP2016505813 A JP 2016505813A JP 2016505813 A JP2016505813 A JP 2016505813A JP 2016519767 A5 JP2016519767 A5 JP 2016519767A5
Authority
JP
Japan
Prior art keywords
biomarkers
expression
biomarkers listed
listed
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016505813A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016519767A (ja
JP6674889B2 (ja
Filing date
Publication date
Priority claimed from GBGB1305940.7A external-priority patent/GB201305940D0/en
Application filed filed Critical
Publication of JP2016519767A publication Critical patent/JP2016519767A/ja
Publication of JP2016519767A5 publication Critical patent/JP2016519767A5/ja
Application granted granted Critical
Publication of JP6674889B2 publication Critical patent/JP6674889B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016505813A 2013-04-02 2014-04-02 前立腺がんに対するバイオマーカー検出における使用のための方法とアレイ Expired - Fee Related JP6674889B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1305940.7A GB201305940D0 (en) 2013-04-02 2013-04-02 Methods and arrays for use in the same
GB1305940.7 2013-04-02
PCT/EP2014/056630 WO2014161910A2 (en) 2013-04-02 2014-04-02 Methods and arrays for use in the same

Publications (3)

Publication Number Publication Date
JP2016519767A JP2016519767A (ja) 2016-07-07
JP2016519767A5 true JP2016519767A5 (enExample) 2017-05-18
JP6674889B2 JP6674889B2 (ja) 2020-04-01

Family

ID=48445139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016505813A Expired - Fee Related JP6674889B2 (ja) 2013-04-02 2014-04-02 前立腺がんに対するバイオマーカー検出における使用のための方法とアレイ

Country Status (12)

Country Link
US (1) US10048265B2 (enExample)
EP (2) EP3557259A3 (enExample)
JP (1) JP6674889B2 (enExample)
KR (1) KR102208140B1 (enExample)
CN (1) CN105283763B (enExample)
AU (1) AU2014247083B2 (enExample)
BR (1) BR112015025255A2 (enExample)
CA (1) CA2908527A1 (enExample)
GB (1) GB201305940D0 (enExample)
HK (1) HK1221504A1 (enExample)
MX (1) MX374601B (enExample)
WO (1) WO2014161910A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11450121B2 (en) * 2017-06-27 2022-09-20 The Regents Of The University Of California Label-free digital brightfield analysis of nucleic acid amplification
WO2020071199A1 (ja) * 2018-10-04 2020-04-09 コニカミノルタ株式会社 補助情報の取得方法
WO2020069580A1 (en) * 2018-10-05 2020-04-09 Minomic International Ltd. Biomarker combinations for determining aggressive prostate cancer
KR102543618B1 (ko) 2021-05-27 2023-06-13 사회복지법인 삼성생명공익재단 전립선암의 엔잘루타미드 저항성 예측용 신규 바이오마커 및 이의 용도
US20250362293A1 (en) * 2022-09-23 2025-11-27 Diesse Diagnostica Senese S.P.A. Apparatus for performing immunometric tests
IT202200019581A1 (it) * 2022-09-23 2024-03-23 Diesse Diagnostica Senese S P A Apparecchiatura per l’esecuzione di test immunometrici

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039578B1 (en) 1980-05-02 1985-04-10 Edward P. Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US20060269971A1 (en) * 2003-09-26 2006-11-30 Mount Sinai Hospital Methods for detecting prostate cancer
CA3086149A1 (en) * 2006-04-04 2007-10-11 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
US20090017463A1 (en) * 2007-07-10 2009-01-15 Vanderbilt University Methods for predicting prostate cancer recurrence
CA2699385A1 (en) * 2007-09-14 2009-03-19 Ventana Medical Systems, Inc. Prostate cancer biomarkers
DK2462449T3 (en) * 2009-08-03 2017-01-09 Yeda Res & Dev Urinary biomarkers for cancer diagnosis

Similar Documents

Publication Publication Date Title
Sadighbayan et al. Recent advances on the DNA-based electrochemical biosensing of cancer biomarkers: Analytical approach
Pantel et al. Detection, clinical relevance and specific biological properties of disseminating tumour cells
JP2016519767A5 (enExample)
JP6138154B2 (ja) 乳癌の予測および診断のためのバイオマーカー
WO2006126008A3 (en) Improved immunoassay methods
JP2011526693A5 (enExample)
JP2016537652A5 (enExample)
CN103097548A (zh) 基于多癌症侵袭相关机制的生物标记
JP2008529008A5 (enExample)
JP2016538545A5 (enExample)
JP6857185B2 (ja) 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法
JP2015505370A5 (enExample)
JP2018504609A5 (enExample)
JP2014509515A5 (enExample)
JP6732914B2 (ja) トリプトファニルtRNA合成酵素を利用した感染症又は感染合併症の診断用組成物と診断マーカー検出方法
US20210123914A1 (en) Prediction of recurrence for bladder cancer by a protein signature in tissue samples
Mengual et al. Gene expression profiles in prostate cancer: identification of candidate non-invasive diagnostic markers
RU2018123581A (ru) Способ для выделения раковых стволовых клеток
EP3545108A1 (en) Biomarkers for the prognosis and diagnosis of cancer
WO2025223207A1 (zh) 胃粘膜肠上皮化生亚型生物标志物folh1及其应用
JP2021019612A (ja) 治療剤に対する抵抗性の診断に使用するためのERCC1アイソフォーム3のmRNAおよび/またはタンパク質ならびにこのmRNAおよび/またはタンパク質を使用する治療剤に対する抵抗性を診断するための方法
CN110331207A (zh) 肺腺癌生物标志物及相关应用
US20230133776A1 (en) Methods for diagnosing cancer
TW201437223A (zh) 胃癌生物標幟物及其用途,以及與胃癌相關之檢測方法
CN116386886A (zh) 预测癌症患者复发模型及设备